🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the potential of high doses of rif...
Status
Completed
Location
University of Florida
Start Date
2013-09
Trial ID
NCT01408914
Treatments Being Tested
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
The purpose of the study is to assess the effects of rifampin on the pharma...
Status
Terminated
Location
Ppd Development
Start Date
2010-03
Trial ID
NCT01068756
Treatments Being Tested
Open-label, parallel, 2-arm, fixed-sequence study to investigate the effect...
Status
Completed
Location
QPS Missouri
Start Date
2020-10-24
Trial ID
NCT04606537
Treatments Being Tested
This is a 2-part, open label, fixed-sequence study to evaluate the potentia...
Status
Completed
Location
Clinical Trial Site
Start Date
2021-06-07
Trial ID
NCT04933682
Treatments Being Tested
This is a single-center, open, single-dose, self-controlled phase I clinica...
Status
Unknown
Location
The First People's Hospital of Changzhou
Start Date
2023-12
Trial ID
NCT06165822
Treatments Being Tested
Studies evaluating the effects of itraconazole or rifampicin on the pharmac...
Status
Completed
Location
Yali Liu
Start Date
2024-03-12
Trial ID
NCT06255951
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
This study is designed to assess 1) the effect of multiple doses of itracon...
Status
Completed
Location
Celerion
Start Date
2019-10-18
Trial ID
NCT04142762
This is a open-label study, 2-treatment, 2-period, single sequence design. ...
Status
Completed
Location
Celerion (MDS Pharma Services)
Start Date
2010-03
Trial ID
NCT02216331
Treatments Being Tested